London-based healthtech startup with co-founders from Poland VitVio has raised $2 million in pre-seed funding. LDV Capital, Bek Ventures, Tiny Supercomputer Investment Company, and angel investors backed the startup. The company is also launching a pilot at the Royal Orthopaedic Hospital, as stated on VitVio’s Linkedin page.

About Vitvio 

  • Founded by Thomas Knox (CEO), Dr. Peter Rennert (CTO), Maks Kozarzewski (COO), and Aleks Pajewski (CPO), VitVio helps to tackle the issue by installing cameras and sensors in operating rooms and integrating them with existing hospital health information systems.

  • VitVio's AI algorithms track and analyze every aspect of the surgical procedure, providing real-time updates and alerts.

  • This data can be used to plan surgeries, optimize resource allocation, and improve overall OR utilization. Shortening the UK waiting list for medical services, which reached 7.6 million in April 2024, a three-fold increase since 2010. 

Investment details

  • Current pre-seed funding was led by LDV Capital, a US-based venture fund investing in early-stage visual technology businesses, partnering with technical teams that use computer vision, machine learning, and AI for data analysis. 

  • Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company and angel investors have also participated in the round.

VitVio's launch at the Royal Orthopaedic Hospital 

  • The Royal Orthopaedic Hospital in the UK has embraced VitVio's cutting-edge AI technology to enhance surgical procedures. 

  • The platform, which autonomously tracks surgical processes and instruments, minimizes human error and adds no extra steps, aligning with industry consensus on the importance of non-invasive technology, according to co-founder Thomas Knox.

“We are excited to be embarking on this partnership with VitVio to take advantage of the technological advances it will help us bring to our theatres. The NHS faces significant challenges and we need to be innovative to find solutions. New technology is one of the areas we are keen to explore – although this partnership is not just about advanced technology. It is about giving our staff the tools they need to focus on what matters most – delivering the best care to patients. By streamlining processes, we look forward to a more efficient surgical experience, ” Steve Washbourne, Executive Director of Finance at ROH, said.

The fresh funding will expand VitVio platform capabilities and deploy technology to partner hospitals, with additional partnerships being finalized in the US, UK, and Europe, with more announcements to follow.